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Abstract
Current emphasis on diagnosing axial spondyloarthritis (axSpA) in early stage enforced the search for sensitive and specific 
diagnostic algorithms with the use of imaging methods. The aim of this review was to summarise current recommendations 
concerning the use of imaging techniques in diagnostics and monitoring of axSpA as well as to outline possible future direc-
tions of the development in this field. MEDLINE database was searched between March and April 2018. In the first phase, 
such keywords were applied: ‘ASAS’, ‘EULAR’, ‘ASAS-EULAR’, ‘ASAS/OMERACT’, ‘axial spondyloarthritis’, while in 
the second step: ‘axial spondyloarthritis’, ‘ankylosing spondylitis’, ‘magnetic resonance imaging’, ‘computed tomography’, 
and ‘radiography’, ‘imaging’. An up-to-date summary of European League Against Rheumatism (EULAR) recommendations 
enriched with recent updates of Assessment of Spondyloarthritis International Society (ASAS) diagnostic criteria regarding 
imaging in axSpA course was created. Moreover, we outlined the role of new in this field, promising imaging techniques, 
such as diffusion-weighted imaging and dynamic contrast-enhanced sequences in magnetic resonance imaging (MRI) or low-
dose computed tomography (CT). As precise monitoring of axSpA activity is vital, we reviewed the most precise methods: 
semiquantitative scores (e.g., Spondyloarthritis Research Consortium of Canada scores or CT Syndesmophyte Score) and 
quantitative analysis of MRI-based apparent diffusion coefficient or perfusion maps and enhancement curves. According to 
EULAR and ASAS recommendations, radiography and MRI still remain basic methods of axSpA diagnostics and monitor-
ing. However, the knowledge of state-of-the-art international guidelines combined with the awareness of emerging imaging 
methods is the key to effective management of axSpA.
Keywords Sacroiliac joints · Axial spondyloarthropathy · Ankylosing spondylitis · EULAR recommendations · ASAS 
recommendations · Magnetic resonance imaging
Introduction
The concept of ‘spondyloarthritis’ describes a heterogeneous 
group of chronic inflammatory rheumatic diseases, which 
subdivides into two categories: axial (axSpA) and periph-
eral (pSpA) spondyloarthropathies [1, 2]. The former group, 
axSpA, gathers broader spectrum of states involving the sac-
roiliac joints (SIJs) and the spine—ankylosing spondylitis 
(AS) and non-radiographic axSpA [3].
Since the major symptom of the axSpA is chronic back 
pain, which is highly prevalent in population and not spe-
cific, it became obvious that definite diagnostic criteria had 
to be established [3]. Apart from clinical symptoms, radio-
logical findings have been integral part of the AS diagnosis 
since the 1930s—especially detected on the SIJs radiogra-
phy, as it is the point of disease origin in almost all cases 
of AS. The first official set of AS diagnostic criteria, which 
included radiological assessment of the SIJs, was the modi-
fied New York (mNY) criteria, published in 1984. Later on, 
the Amor (1990) and European Spondyloarthropathy Study 
Group criteria (1991), created for the diagnosis of spondy-
loarthropathies in general, contained the same definition of 
sacroiliitis as mNY criteria [4].
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Nonetheless, it was the Assessment of Spondyloarthri-
tis International Society (ASAS) criteria for axSpA (2009) 
which triggered real breakthrough in diagnostics of this 
disabling condition. The creation of separate diagnostic 
arm based on the radiological visualisation of sacroili-
itis and incorporating magnetic resonance imaging (MRI) 
as a sufficient method of SIJ inflammation detection, put 
enormous emphasis on the importance of radiology in the 
diagnosis of axSpA [5]. Capturing the disease on early, pre-
radiographical stage, what became possible owing to MRI, is 
especially relevant in term of quick implementation of effec-
tive therapy—namely, TNF inhibitors, which are approved 
in Europe also for non-radiographic axSpA [6].
On the other hand, a lot of authors criticise the ASAS 
criteria [6–9], predominantly because of heterogeneity 
in clinical characteristics and response to TNF inhibitors 
between populations diagnosed by imaging and clinical arms 
[8]. Another raised question is a tendency to lower speci-
ficity of imaging arm in previously unselected population 
with chronic back pain, as lesions of mechanical origin may 
mimic changes characteristic for axSpA on MRI [9]. Thus, 
staying up-to-date with current recommendations of inter-
national societies (e. g., European League Against Rheu-
matism—EULAR, ASAS) and regular search for more and 
more specific methods of axSpA evaluation is crucial for 
physicians dealing with this subject professionally.
The aim of this review was to summarise current recom-
mendations regarding the use of imaging methods in diag-
nostics and monitoring of axSpA and to outline possible 
future directions of development in this field which may 
improve an effectiveness of early axSpA detection.
Search strategy
A comprehensive search of the MEDLINE database was 
conducted in the period between March and April 2018. 
The final search was carried out on 6 April 2018. Only pub-
lished data written in English was taken into account. In 
the first phase of the search, such keywords were applied as 
‘ASAS’ or ‘EULAR’ or ‘ASAS-EULAR’ or ‘ASAS/OMER-
ACT’ and ‘axial spondyloarthritis’ to obtain only up-to-date 
recommendations of international societies regarding the use 
of imaging in diagnosis and management of axial spondy-
loarthritis. Preference was given to the sources published 
within the past 9 years. In the next step, the search was con-
ducted with the use of the following keywords: ‘axial spon-
dyloarthritis’ or ‘ankylosing spondylitis’ and ‘magnetic reso-
nance imaging’ or ‘computed tomography’ or ‘radiography’ 
or ‘imaging’. Titles and abstracts were analysed to identify 
articles covering the topic of promising imaging methods 
which have not been investigated thoroughly yet in the field 
of axSpA as well as quantitative and semiquantitative meth-
ods of axSpA assessment with the use of imaging. In this 
case, preference was given to articles published since 2005. 
In addition, reference lists of articles which met inclusion 
criteria in both cases were screened for other eligible studies.
Assessment of the sacroiliac joints
Conventional radiography (CR)
According to EULAR recommendations (2015) [1]:
1. CR of the SIJs is advised as the first imaging technique 
to diagnose sacroiliitis associated with axSpA.
2. CR of the SIJs may be used for long-term structural 
damage monitoring in axSpA—especially new bone 
formation.
The radiographic definition of axSpA-related sacroiliitis 
currently used in EULAR recommendations and the imaging 
arm of ASAS axSpA diagnostic criteria, which is equal to 
mNY criteria, is [5]:
1. Bilateral sacroiliitis grade ≥ II.
2. Unilateral sacroiliitis grade ≥ III.
Details regarding particular grades are shown in Table 1 
[4].
The primary drawback of CR in the assessment of SIJs 
is that it enables to visualise only late, post-inflammatory 
changes—capturing the disease on such advanced stage may 
Table 1  Grading of radiographic sacroiliitis
Grade Stage Explanation
0 Normal Unchanged morphology of the joint
I Suspicious Blurring of the joint margins
II Minimal abnormality Small localised areas of erosions or sclerosis, without alteration of the joint width
III Unequivocal abnormality Moderate/advanced sacroiliitis: ≥ 1 out of: erosions, sclerosis, widening/narrow-
ing of the joint space, partial ankylosis
IV Severe abnormality Total ankylosis
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significantly diminish the positive effect of biologic therapy, 
which is effective only with coexisting acute inflammatory 
changes. Moreover, due to the complex anatomy of the SIJs, 
multiple techniques of their visualisation and highly subjec-
tive classification of the sacroiliitis signs, the reliability of 
this method in less evident cases is arguable. However, up to 
this point, any other imaging method has not surpassed the 
CR in terms of cost-effectiveness, widespread availability, 
and relatively low dose of ionizing radiation. Hence, the 
CR most likely remains the basic modality used for sacroili-
itis detection in forthcoming years [10]. There may only be 
an attempt made to implement more objective radiographic 
classification of the SIJs structural damage than existing 
mNY criteria.
Computed tomography (CT)
According to EULAR recommendations (2015) [1]:
1. CT might provide additional information on structural 
damage if CR is negative and MRI contraindicated or 
cannot be performed.
CT is regarded as a gold standard of the SIJs structural 
damage detection [11]. Nonetheless, the most important sign 
of active inflammation of the SIJs—bone-marrow oedema—
is not visible on this imaging modality. The same applies to 
fatty degeneration of bone marrow, which is an indicator of 
the early phase of chronic joint inflammation [4]. Combin-
ing aforementioned difficulties with high dose of ionizing 
radiation and relatively high costs, when compared to CR, 
reluctance towards CT use in diagnostics of axSpA does 
not come as a surprise. On the other hand, low-dose CT 
of the SIJs seems to be very promising technique and may 
have a chance to replace CR as a method of structural dam-
age and new bone formation monitoring [12, 13]. Another 
promising method is spectral CT, which enables to measure 
both calcium and water concentration within a tissue. As a 
consequence, the visualisation and quantitative analyses of 
the bone-marrow oedema within the SIJs are possible and 
this method may be a leap forward more accurate diagnosis 
of the axSpA [14, 15].
Magnetic resonance imaging
According to EULAR recommendations [1]:
1. In some cases, such as young age of the patient or short 
symptom duration, MRI of the SIJs is an alternative to 
CR first imaging method of axSpA diagnosis.
2. When the diagnosis of axSpA cannot be established 
based on clinical features along with CR and axSpA is 
still suspected, MRI of the SIJs is recommended. Con-
sider the presence of both active inflammatory lesions 
(bone-marrow oedema) and structural lesions (bone ero-
sion, new bone formation, sclerosis, and fat infiltration).
3. MRI of the SIJs may be used to assess and monitor dis-
ease activity in axSpA providing additional information 
to clinical and biochemical assessments. The decision 
regarding repeating MRI depends on the clinical circum-
stances. Short tau inversion recovery (STIR) sequences 
are sufficient to detect inflammation.
4. MRI of the SIJs may provide additional information in 
monitoring of their structural changes.
5. Extensive MRI inflammatory activity (bone-marrow 
oedema) might be used as a predictor of good clinical 
response to anti-TNFα treatment in axSpA. Hence, MRI 
might aid in the decision of initiating biologic therapy, 
in addition to clinical features and CRP.
As far as axSpA diagnosis is concerned, the imaging arm 
of the ASAS criteria as one of the two equivalent defini-
tions of sacroiliitis includes signs of acute inflammation 
highly suggestive of axSpA on MRI of the SIJs [5]. The 
latest update of the definition of active sacroiliitis in the 
course of axSpA by the ASAS MRI working group (2015) 
equate active inflammation on MRI only with bone-marrow 
oedema/osteitis and did not extend the definition of other 
active inflammatory lesions (such as capsulitis, synovitis, 
and enthesitis) or signs of chronic inflammatory changes 
(such as erosions, sclerosis, fat deposition, and bony bridges/
ankylosis) [4, 16]. Precise definition of bone-marrow 
oedema according to aforementioned criteria is a presence 
of bone-marrow lesion, which is hyperintense on water-sen-
sitive T2-weighted sequences (e.g., STIR or fat-suppressed 
T2-weighted) or enhancing on T1-weighted sequences after 
the contrast media administration. If one lesion is present, 
it must be visible on two consecutive slices of an MRI scan, 
while the presence of at least two lesions on one slice is 
sufficient to diagnose sacroiliitis. As well, the lesion must 
be located in the subchondral bone in the region adjacent 
to articular surface of the SIJs [16]. An example of typical 
bone-marrow oedema lesion in the SIJs is shown in Fig. 1.
Although some authors proposed the inclusion of struc-
tural lesions to the definition of sacroiliitis highly sugges-
tive of axSpA [17, 18], there were too many discrepancies 
with regard to a precise definition of these structural changes 
appearance on MRI to include them in the final version of 
the updated sacroiliitis definition. Nonetheless, in cases 
when it is questionable if lesions visualised on the SIJs MRI 
are “highly suggestive of axSpA”, the evaluation of struc-
tural changes within the SIJs (especially erosions) might be 
beneficial for reaching the final diagnosis [16].
There exists a wide range of scoring systems facilitat-
ing quantitative evaluation of active sacroiliitis on MRI, but 
the best performing one is the Spondyloarthritis Research 
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Consortium of Canada (SPARCC) score [19], proposed by 
Maksymowych et al. [20]. This method is based on the eval-
uation on STIR sequence six consecutive semicoronal slices 
focusing on the synovial part of the SIJ, in the direction from 
posterior to anterior. Each SIJ is divided into four quadrants 
(upper iliac, lower iliac, upper sacral, and lower sacral) and 
every one of them is separately assessed. First, each quadrant 
is analysed for the presence of the hyperintense lesions in 
STIR sequence and scored dichotomously (0 = normal sig-
nal, 1 = present lesion of increased intensity). Each quadrant 
could also receive an additional one point for the presence of 
intense signal within the lesion, and the next one for continu-
ously increased signal for ≥ 1 cm from the articular surface. 
Summing it up, every slice maximally could get 12 points, 
what gives 72 points for all six slices [20]. Although assess-
ment of the chronic inflammatory changes is not mandatory 
to diagnose axSpA, it is still worth performing their quanti-
tative evaluation even for purposes of more objective disease 
monitoring. Analogous to previously mentioned SPARCC 
score for active inflammatory changes, the SPARCC MRI 
sacroiliac joint structural score (SSS) enables to appraise the 
presence of fat metaplasia, erosion, backfill, and ankylosis 
[21].
All current guidelines regarding the diagnostics and mon-
itoring of the axSpA with the use of MRI advise only the use 
of a few basic sequences (fat-suppressed T2-weighted, STIR, 
fat-suppressed contrast-enhanced T1-weighted sequences). 
Nevertheless, the advancement in the field of MRI imaging 
leads to the popularization of diffusion-weighted imaging 
(DWI) combined with apparent diffusion coefficient (ADC) 
maps, and dynamic contrast-enhanced (DCE) sequences, 
also in rheumatology. Example of these techniques’ appli-
cation in the visualisation of active inflammatory lesions of 
patients with axSpA is shown in Figs. 2 and 3. However, 
utility of both these sequences in the assessment of axSpA 
arouses controversy for the time being. On one hand, the 
majority of the current studies describes these sequences as 
highly sensitive methods of early sacroiliitis diagnosis and 
its effective differentiation, additionally enabling quantita-
tive assessment of inflammatory changes for purposes of the 
disease activity monitoring [22–25]. An example of such 
quantitative analysis of enhancement curve within the area 
of active inflammatory lesion compared to unaffected area 
based on DCE sequence is presented in Fig. 4. On the other 
hand, some authors question the beneficial value of incorpo-
rating these sequences to the basic image acquisition proto-
col used for diagnostics of axSpA [26]. Taking into account 
that up to this point, the literature on this topic is very lim-
ited, the use of DWI and DCE sequences in the diagnostics, 
differentiation, and quantitative monitoring of the axSpA 
seems to be the promising topic for future research. How-
ever, DWI appears to be more beneficial, because it is fast 
sequence which does not require gadolinium administration.
Fig. 1  Typical axSpA bone-marrow oedema lesion (white arrow) in the lower sacral quadrant of the left sacroiliac joint on STIR sequence (a) 
and contrast-enhanced T1-weighted sequence (b). STIR, short tau inversion recovery
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Another auspicious modality which is extensively inves-
tigated in rheumatology is whole-body MRI, which allows 
to comprehensively evaluate axial and peripheral articular 
inflammatory changes along with enthesitis [27–29]. The 
general assessment of the whole musculoskeletal system 
appears as the potentially effective tool of axSpA differen-
tiation and detailed disease activity monitoring.
Other imaging modalities
According to EULAR recommendations [1]:
1. Scintigraphy and ultrasound are not recommended for 
diagnosis of sacroiliitis as a part of axSpA.
Fig. 2  Active inflammatory lesion in the course of axSpA (white arrow) located in the iliac part of the left sacroiliac joint on DWI (b = 800) 
sequence (a) and colour ADC map (b). DWI, diffusion-weighted imaging; ADC, apparent diffusion coefficient
Fig. 3  Active inflammatory lesion in the course of axSpA (white arrow) situated in the iliac part of the left sacroiliac joint visualised with use of 
DCE sequence (a) and maximal perfusion colour-coded map (b)
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2. Future research agenda: investigation of new/alternative 
imaging technologies which may be potentially useful 
for clinical purposes (ultrasound—new transducers, 
Doppler quantification, elastosonography; new nuclear 
medicine techniques; optical imaging).
At this moment, recommendations do not include ultra-
sonography as a sufficient method of axSpA-related sacro-
iliitis diagnosis and monitoring. As the ultrasonography is 
imaging method which is the most dependent on its operator 
experience, when combined with the anatomic complexity 
of this region, it significantly limits the daily usage of this 
method in axSpA diagnostics and management. Nonetheless, 
since it allows to visualise articular and soft-tissue periar-
ticular involvement of the SIJs, it may be considered as one 
of the methods facilitating early axSpA diagnosis in less 
evident cases [30, 31]. Colour and duplex Doppler sonogra-
phy with or without the use of specific contrast media may 
turn out as a perfect tool for long-term monitoring of the 
SIJs inflammation activity and response to treatment, as it 
is suggested in some preliminary reports [32, 33].
Moving to nuclear medicine techniques, bone scintigra-
phy was widely used for axSpA-related sacroiliitis detec-
tion in the past, thanks to the capability of illustrating the 
regions of inflammation and high bone turnover within the 
SIJs. Nevertheless, this technique was superseded by MRI, 
as a consequence of its low sensitivity, specificity, and accu-
racy [31]. Popularization of the hybrid imaging methods in 
rheumatology may be a new hope of early axSpA diagnosis. 
Up to this point, few studies focusing on the use of 18F-PET/
MR and 18F-PET/CT were published. Although the data on 
the utility of these methods in the field of axSpA are sparse, 
yet they suggest that they may be advantageous in terms of 
detection of future new bone formation areas (visualisation 




According to EULAR recommendations [1]:
1. CR of the spine might be used for long-term monitor-
ing of structural damage in axSpA, especially new bone 
formation.
2. In patients with AS, initial CR of the lumbar and cer-
vical spine is recommended to detect syndesmophytes, 
which are predictors of new syndesmophytes formation.
The role of the CR of the spine in fact is limited to the 
monitoring of late stage of axSpA progression, namely, AS, 
as only chronic changes, such as ankylosis and syndesmo-
phytes, are visible there [4]. As far as semiquantitative meth-
ods of spinal structural changes scoring is concerned, the 
most popular and reliable one is the modified Stoke Anky-
losing Spondylitis Spinal Score (mSASSS) [4]. This method 
of evaluation base on the assessment of anterior corners of 
cervical and lumbar spine vertebrae in the lateral view—
from the lower border of C2 to the upper border of Th1 and 
from the lower border of Th12 to the upper border of S1 
(including). Each corner is scored from the 0 to 3 points, 
depending on its morphology (0—normal; 1—sclerosis, 
Fig. 4  Area under the perfusion curve colour-coded map of the sacral 
region of the person with axSpA, with marked inflammatory lesion in 
the upper iliac quadrant of the left sacroiliac joint (Roi 1, blue line) 
and respective unaffected area in the right sacroiliac joint (Roi 2, 
orange line) (a). The graph of relative percentage enhancement ver-
sus time of acquisition showing the pattern of enhancement in typical 
axSpA active inflammatory lesion (Roi 1, blue line) in comparison to 
intact, non-enhancing tissue (Roi 2, orange line) (b)
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squaring or erosion; 2—syndesmophyte; 3—bony bridge), 
and the maximal possible score is 72 points [4].
Computed tomography
CT of the spine is not included in any set of recommen-
dations as an advised method of the spine structural dam-
age assessment. In general, it is understandable, taking into 
account the extremely high dose of ionizing radiation during 
CT examination of such large area as the spine and satis-
factory performance of spine CR. Nonetheless, CR assess-
ment, especially only with the use of the mSASSS score, 
omits evaluation of frequently affected by axSpA thoracic 
vertebrae as well as posterior vertebral corners and facet 
joints. In addition, the imprecise character of CR images 
hinders the short-term progression evaluation, as it may take 
up to 2 years to observe axSpA radiographic progression 
[13]. These drawbacks of CR lead to the development in the 
field of low-dose CT as a possible method of chronic bony 
changes assessment in the spine. This technique detects sig-
nificantly more bony proliferation lesions than CR combined 
with the mSASSS scoring system [37].
Newly proposed CT Syndesmophyte Score (CTSS) seems 
to be a reliable tool for precise assessment of new bone for-
mation in the course of AS with the use of low-dose CT 
[38]. The spine is analysed in two planes: sagittal and coro-
nal, where the anterior + posterior rim and the right + left 
rim are assessed, respectively—in summary four quadrants. 
Every vertebra is additionally divided in upper and lower 
half, which are evaluated separately. The score takes into 
account the area from the bottom half of the C2 vertebra to 
the upper half of S1 vertebra (including). Every quadrant of 
vertebrae half is scored with 0 to 3 points—details concern-
ing the rules of scoring are demonstrated in Table 2. Maxi-
mal possible score is 552 points [38]. This method, apart 
from the precise monitoring of AS progression, enables to 
quantitatively analyse the effect of biological therapy on new 
syndesmophytes formation.
Magnetic resonance imaging
According to EULAR recommendations [1]:
1. MRI of the spine is not generally recommended in the 
diagnostics of axSpA.
2. MRI of the spine may be used to evaluate and monitor 
the axSpA activity, providing additional information to 
clinical and biochemical assessments.
3. MRI of the spine may be used to predict development of 
new, radiographic syndesmophytes—especially relevant 
are such changes as vertebral corner inflammatory or 
fatty lesions.
4. Extensive inflammatory activity, particularly on MRI 
of the spine of patients with AS, may be used as a pre-
dictor of good clinical response to anti-TNFα treatment 
in axSpA. As well, it may aid the decision of starting 
biologic therapy, in addition to clinical examination and 
CRP.
The principal active inflammatory lesion which is 
detected on MRI of the spine in patients with axSpA is bone-
marrow oedema in the area adjacent to: anterior and poste-
rior corners of vertebrae (spondylitis), vertebral endplates 
(spondylodiscitis), insertions of the anterior and posterior 
longitudinal ligaments (osteitis related to enthesitis), or facet 
and costovertebral joints (arthritis). As well, enthesitis of 
the spinal ligaments may be visible. Chronic inflammatory 
changes, which could appear in the course of axSpA, are: fat 
deposition on vertebral corners, erosions, syndesmophytes, 
and ankylosis [4, 39]. However, according to ASAS consen-
sus (2012), it is the anterior and posterior spondylitis along 
with fatty depositions on vertebral corners which are lesions 
typical for axSpA. If anterior/posterior spondylitis is located 
in three or more sites in the spine and fatty depositions on 
several vertebral corners, they could be classified as highly 
suggestive of axSpA, especially in younger patients. The rest 
of inflammatory or structural changes are either non-specific 
or not sufficiently investigated yet to include them in final 
consensus [39]. Nonetheless, the assessment of MRI of the 
spine may only play supporting role in the diagnostics of 
the axSpA. The ASAS MRI working group did not recom-
mend adding MRI of the spine into the definition of positive, 
suggestive of axSpA MRI as not beneficial for reaching the 
diagnosis, since the group of patients with positive MRI of 
the spine and negative MRI of the SIJ is marginal [16, 40]. 
Yet, it still could be a great method of disease activity and 
response to treatment monitoring.
Analogical to the one applying to MRI of the SIJs, there 
is a quantitative analysis method dedicated to the spine, 
called SPARCC spine inflammation score. Discovertebral 
units, namely, an intervertebral disc and adjacent endplates, 
are divided into four quadrants: lower anterior, lower pos-
terior, upper anterior, and upper posterior endplates. If 
the increased signal is identified in particular quadrant, it 
receives 1 point, if not, 0 points. One additional point could 
be added for the presence of intense signal and another for 
Table 2  Scoring system of syndesmophytes according to the CT Syn-
desmophyte Score
Score Description of changes
0 Syndesmophyte absent
1 Syndesmophyte reaches < 50% of the intervertebral disc space
2 Syndesmophyte reaches ≥ 50% of the intervertebral disc 
space, but does not form the bridge
3 Syndesmophyte bridge
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the lesion ≥ 1 cm in depth. Each quadrant is assessed in three 
consecutive sagittal slices, which gives a maximal score of 
18 per whole discovertebral unit. This method of evalua-
tion should be applied to 6 affected discovertebral units, 
and therefore, the maximal possible score is 108 points. 
The whole analysis should be performed on fat-suppressed 
T2-weighted or STIR sequence [41].
Basic sequences used for the spine imaging in MR are: 
T1-weighted, fat-suppressed T2-weighted, STIR, and post-
gadolinium fat-suppressed T1-weighted sequence [39]. The 
role of other sequences, such as DWI and DCE, is almost 
unexplored yet. There is only one report on this topic [42], 
which suggest that DWI is a sensitive and quick method 
of spinal active inflammatory changes’ evaluation. This 
remains another prospective branch which may significantly 
facilitate diagnosis and progression monitoring of axSpA 
in future.
Conclusion
According to the EULAR and ASAS recommendations, 
conventional radiography and magnetic resonance imaging 
remain the basic methods of axSpA diagnosis, monitoring 
and response to treatment assessment. However, there is 
still a need to search for more accurate methods of early 
diagnosis and progression assessment, and alternative MRI 
sequences (DWI, DCE sequences), low-dose CT and hybrid 
imaging may be these missing links.
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